Company Overview

Update
Founders:
Robert Mc Neil
Headquarters:
St Louis, MO
IPO:
Went Public on Aug 20, 2004
Stock:
NASDAQ:STXS
Categories:
Biotechnology

Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases.

Description

Update

Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.

Current Team (3)

Update

Board Members and Advisors (1)

Update

Funding Rounds (1) - $10M

Update

Offices/Locations (1)

Update
  • Office

    4320 Forest Park Avenue

    Suite 100

    St Louis, MO 63108

    USA